PT Kalbe Farma Tbk. (PTKFF)

Market Cap	3.26B
Revenue (ttm)	2.06B
Net Income (ttm)	209.31M
Shares Out	n/a
EPS (ttm)	0.00
PE Ratio	15.55
Forward PE	14.38
Dividend	0.00 (3.08%)
Ex-Dividend Date	Jun 4, 2025

Volume	700
Average Volume	15,504
Open	0.0718
Previous Close	0.0825
Day's Range	0.0718 - 0.0718
52-Week Range	0.0626 - 0.0958
Beta	0.02
RSI	42.20
Earnings Date	Feb 18, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company pro...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,903
• Stock Exchange: OTCMKTS
• Ticker Symbol: PTKFF

Financial Performance

In 2024, PT Kalbe Farma Tbk.'s revenue was 32.63 trillion, an increase of 7.16% compared to the previous year's 30.45 trillion. Earnings were 3.24 trillion, an increase of 17.13%.

Financial numbers in IDR